These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39247829)

  • 41. Long non‑coding RNA
    Wang K; Hu YB; Zhao Y; Ye C
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of YAP1 Reduces YTHDF3 to Stabilize
    Qiu D; Gao L; Yu X
    Discov Med; 2024 Jul; 36(186):1486-1498. PubMed ID: 39054719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
    Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
    Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA‑93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionω.
    Ma C; Peng P; Zhou Y; Liu T; Wang L; Lu C
    Mol Med Rep; 2020 Jul; 22(1):483-493. PubMed ID: 32319642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway.
    Ji J; Cheng Z; Zhang J; Wu J; Xu X; Guo C; Feng J
    J Cell Mol Med; 2024 Apr; 28(8):e18335. PubMed ID: 38652216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.
    Shen C; Liu J; Xie F; Yu Y; Ma X; Hu D; Liu C; Wang Y
    Cancer Lett; 2024 Jul; 595():217002. PubMed ID: 38823761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 50. LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma.
    Guo C; Liang C; Yang J; Hu H; Fan B; Liu X
    Oncol Rep; 2019 May; 41(5):2753-2761. PubMed ID: 30896861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hippo pathway inactivation through subcellular localization of NF2/merlin in outer cells of mouse embryos.
    Goda N; Ito Y; Saito S; Suzuki M; Bai H; Takahashi M; Wakai T; Kawahara M
    Development; 2024 Jul; 151(14):. PubMed ID: 39077779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiomics characterization of mouse hepatoblastoma identifies yes-associated protein 1 target genes.
    Rodríguez TC; Kwan SY; Smith JL; Dadafarin S; Wu CH; Sontheimer EJ; Xue W
    Hepatology; 2023 Jul; 78(1):58-71. PubMed ID: 35932276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner.
    Ikeuchi M; Yuki R; Saito Y; Nakayama Y
    FASEB J; 2021 Jan; 35(1):e21242. PubMed ID: 33368671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma.
    Wang J; Xiu M; Wang J; Gao Y; Li Y
    J Hematol Oncol; 2024 Sep; 17(1):78. PubMed ID: 39218945
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Kim E; Kang JG; Kang MJ; Park JH; Kim YJ; Kweon TH; Lee HW; Jho EH; Lee YH; Kim SI; Yi EC; Park HW; Yang WH; Cho JW
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14259-14269. PubMed ID: 32513743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.
    Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L
    J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2.
    Han LL; Yin XR; Zhang SQ
    Int J Oncol; 2018 Dec; 53(6):2433-2444. PubMed ID: 30272278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.